Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00853463 · ClinicalTrials.gov registry record · NA

Discharge ALERT: Quality Improvement Initiative

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
2,515
Enrollment target

NCT00853463: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT00853463 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,515 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00853463, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
2,515 participants
Enrollment target

Study Summary

Brigham and Women's Hospital will coordinate a Quality Improvement Initiative at other hospitals that focuses on whether physician notification prior to discharge of high risk VTE patients will reduce the incidence of VTE after hospital discharge.

Interventions

  • BEHAVIORAL Alert

Trial Details

FieldValue
Enrollment Target 2,515 participants
Start Date 2009-04
Est. Completion 2011-05
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT00853463 record still lists

NCT00853463 is an interventional study that assigns participants to a tested intervention. Its 2,515 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% higher).

The record links to 0 conditions, and to 1 intervention - of which Alert is the first listed.

NCT00853463 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00853463 about?

NCT00853463 is a clinical study titled "Discharge ALERT: Quality Improvement Initiative". Brigham and Women's Hospital will coordinate a Quality Improvement Initiative at other hospitals that focuses on whether physician notification prior to discharge of high risk VTE patients will reduce the incidence of VTE after hospital discharge.

What is the current status of trial NCT00853463?

This trial is currently completed. It is a NA study. The enrollment target is 2,515 participants. The study started on 2009-04. Estimated completion is 2011-05.

What interventions are being tested in trial NCT00853463?

The interventions under investigation include: Alert (BEHAVIORAL).

Who is sponsoring clinical trial NCT00853463?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00853463's enrollment target sits among peer trials

2,515 44th of 2000 higher than 1,957 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04142177 · 2,529 participants · NA

    Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

  • NCT00018057 · 2,530 participants · Phase 2

    Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00853463, the US trial registry maintained by the National Library of Medicine. NCT00853463 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.